Sean E Harper - Net Worth and Insider Trading
Sean E Harper Net Worth
The estimated net worth of Sean E Harper is at least $17 Million dollars as of 2024-11-13. Sean E Harper is the EVP, Research & Development of Amgen Inc and owns about 56,082 shares of Amgen Inc (AMGN) stock worth over $17 Million. Details can be seen in Sean E Harper's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sean E Harper has not made any transactions after 2018-07-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sean E Harper
Sean E Harper Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sean E Harper owns 2 companies in total, including Amgen Inc (AMGN) , and Acelyrin Inc (SLRN) .
Click here to see the complete history of Sean E Harper’s form 4 insider trades.
Insider Ownership Summary of Sean E Harper
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AMGN | Amgen Inc | 2018-07-16 | EVP & Research & Development |
SLRN | Acelyrin Inc | 2023-05-04 | 10 percent owner |
Sean E Harper Latest Holdings Summary
Sean E Harper currently owns a total of 1 stock. Sean E Harper owns 56,082 shares of Amgen Inc (AMGN) as of July 16, 2018, with a value of $17 Million.
Sean E Harper Form 4 Trading Tracker
According to the SEC Form 4 filings, Sean E Harper has made a total of 0 transactions in Amgen Inc (AMGN) over the past 5 years. The most-recent trade in Amgen Inc is the sale of 1,525 shares on July 16, 2018, which brought Sean E Harper around $298,458.
Insider Trading History of Sean E Harper
- 1
Sean E Harper Trading Performance
Sean E Harper Ownership Network
Ownership Network List of Sean E Harper
Ownership Network Relation of Sean E Harper
Sean E Harper Owned Company Details
What does Amgen Inc do?
Who are the key executives at Amgen Inc?
Sean E Harper is the EVP & Research & Development of Amgen Inc. Other key executives at Amgen Inc include SVP & CCO Nancy A. Grygiel , SVP & Gen. Counsel & Secy. Jonathan P Graham , and VP & Finance & CAO Matthew C. Busch .
Amgen Inc (AMGN) Insider Trades Summary
Over the past 18 months, Sean E Harper made no insider transaction in Amgen Inc (AMGN). Other recent insider transactions involving Amgen Inc (AMGN) include a net sale of 4,213 shares made by Nancy A. Grygiel , a net sale of 10,000 shares made by Jonathan P Graham , and a net sale of 9,558 shares made by Murdo Gordon .
In summary, during the past 3 months, insiders sold 0 shares of Amgen Inc (AMGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 23,771 shares of Amgen Inc (AMGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 23,771 shares.
Amgen Inc (AMGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Amgen Inc Insider Transactions
Sean E Harper Mailing Address
Above is the net worth, insider trading, and ownership report for Sean E Harper. You might contact Sean E Harper via mailing address: Amgen Inc., One Amgen Center Drive, Thousand Oaks Ca 91320-1799.